Pharma Industry News

NICE recommends for online and mobile depression programme for trial on NHS

Written by David Miller

NICE has said that a new online and mobile app should be trialled on the NHS in the treatment of depression, after finding that it enabled patients faster access to care.

Deprexis, as the programme is known, is based on the principles of cognitive behavioural therapy (CBT) and is available on any device with internet access such as smartphones or desktop computers. The system allows for patients to exchange messages with health professionals, and enables therapists to easily monitor patient symptoms.

read more

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]